Here's why these 4 stocks are soaring higher today

Novogen Limited (ASX:NRT) and Qantas Airways Limited (ASX:QAN) are among today's top performers.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P / ASX 200 (Index: ^AXJO) (ASX: XJO) finished in the red today, but that's not stopped several stocks flying out of the blocks for varying reasons.

Let's take a look at some of today's top performers and consider whether they have room to climb higher.

Qantas Airways Limited (ASX: QAN) has taken off to climb 3.1% to a multi-year high of $3.30 as it basks in the glory of its recently posted $367 million profit before tax in the first half of financial year 2015. The airline's bottom line is being supported by a major cost-cutting program and the powerful tailwind of falling fuel bills.

Up 178% over the past year the stock has hit a sweet spot, but the high fixed-cost base mean it's probably a business to enjoy as a passenger not an investor.

Triton Minerals Ltd (ASX: TON) is a junior graphite miner that on April 1 announced a US$2 billion graphite supply agreement with a Chinese customer. The stock has been on a wild ride ever since, almost doubling in value to 61 cents before crashing back down to close at 39.5 cents, after a near 10% rise today.

Evidently the market is unsure how to value the business given the myriad future assumptions round revenue generation and investors would be advised to leave this one to the day traders for now.

Novogen Limited (ASX: NRT) is a biotech hopeful that rocketed up 43% to a record high of 32 cents today after it announced that one of its drug candidates named Anisina has seen reported success in killing melanoma cells irrespective of their mutational status.

Novogen says the results support its aim of conducting a clinical study in patients with late-stage melanoma using a combined treatment of Anisina and vincristine. Novogen also says Anisina is showing potential to be a widely-used anti-cancer drug across different cancers, although it has several major hurdles to negotiate before it can attempt to gain regulatory approval for its commercialisation.

Speculative biotech stocks are not for the faint hearted, as price swings can be wild and the science behind them difficult to understand for ordinary investors.

Elders Ltd (ASX: ELD) is an agribusiness that has climbed 5.4% today despite releasing no news to the market. The business is a potential turnaround story after posting a net profit of $3 million for the year ending 30 September 2014, after a series of giant losses in prior years. Since the positive result was announced investors have warmed to the agribusiness's turnaround prospects.

Agricultural businesses have some reasonable tailwinds, but the high costs and unpredictable climatic conditions mean they don't tend to be the best bet for consistent long-term returns.

Motley Fool contributor Tom Richardson has no financial interest in any company mentioned. You can find him Twitter @tommyr345

We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policyThis article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »